Journal of Gene and Cell Metabolism in Medicine

JGCMM welcomes submissions in, but not limited to, the following areas that have clear translational implications for human health and disease: gene regulation and expression (including mechanisms of transcriptional and post-transcriptional control, alternative splicing, epigenetics, non-coding RNAs, and gene mutations), biochemistry and cellular signaling (such as protein synthesis, processing, post-translational modifications, intracellular trafficking, biochemical signaling pathways, and regulatory networks), cellular metabolism (including metabolic pathways, cell bioenergetics, cell-to-cell communication, metabolic reprogramming in disease, and the integration of nutritional supplements with metabolism, gene expression, and signaling), omics and systems biology (genomics, transcriptomics, proteomics, metabolomics, and integrative multi-omics approaches), pharmacology and therapeutics (targeting gene and protein function, drug discovery, pharmacogenomics, and the development of novel therapeutic strategies including nutraceuticals and epigenetic modulators), autophagy and lysosomal function (the role of autophagy, lysosomal pathways, and protein degradation in cell homeostasis, disease pathogenesis, and therapy), cellular processes (cell death, differentiation, proliferation, motility, secretion, and their dysregulation in pathological conditions), as well as translational and clinical studies that apply molecular and cellular findings to the diagnostics, prognostics, and treatment of human diseases.